Seoul, South Korea

Jun-Geol Ryu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Taebak, KR (2016)
  • Taebaek-si, KR (2017)
  • Seoul, KR (2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jun-Geol Ryu

Introduction

Jun-Geol Ryu is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the development of compositions for treating various health conditions. With a total of three patents to his name, Ryu's work focuses on innovative solutions for complex medical issues.

Latest Patents

One of Ryu's latest patents is a composition designed for alleviating, preventing, or treating rheumatoid arthritis. This composition includes a newly isolated agent that has shown potent efficacy in treating rheumatoid arthritis, making it a promising candidate for future rheumatoid arthritis medications or probiotic materials. Another significant patent involves a composition comprising metformin as an active ingredient for preventing or treating inflammatory bowel disease. This invention highlights the effectiveness of metformin in maintaining intestinal health and its potential use in treating autoimmune diseases.

Career Highlights

Throughout his career, Jun-Geol Ryu has worked with reputable organizations, including the Catholic University Industry Academic Cooperation Foundation and Bifido Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Ryu has collaborated with several professionals in his field, including Mi-La Cho and Seon-Yeong Lee. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Jun-Geol Ryu's contributions to medical innovation through his patents demonstrate his commitment to improving health outcomes. His work continues to pave the way for advancements in treatments for rheumatoid arthritis and inflammatory bowel disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…